You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 3
  • 456 Comparisons of clinical outcomes in women with advanced ovarian cancer treated with frontline intraperitoneal versus dose-dense platinum/paclitaxel chemotherapy without bevacizumab

Article metrics

Article menu

Download PDFPDF

Poster
IGCS20_1497
456 Comparisons of clinical outcomes in women with advanced ovarian cancer treated with frontline intraperitoneal versus dose-dense platinum/paclitaxel chemotherapy without bevacizumab
Free

 

Online download statistics by month:

Online download statistics by month: November 2020 to April 2024

AbstractFullPdf
Nov 20202408
Dec 20201609
Jan 2021605
Feb 2021402
Mar 2021402
Apr 2021803
May 2021201
Jun 2021101
Jul 2021003
Aug 2021102
Sep 2021003
Oct 20216019
Nov 20214014
Dec 2021602
Jan 2022600
Feb 20221001
Mar 2022401
Apr 2022600
May 20221009
Jun 2022604
Jul 20222200
Aug 20221304
Sep 2022506
Oct 2022401
Nov 2022900
Dec 20221802
Jan 2023601
Feb 2023401
Mar 2023401
Apr 2023300
May 2023400
Jun 2023402
Jul 2023402
Aug 2023802
Sep 2023603
Nov 20231002
Dec 20234801
Jan 20242700
Feb 2024401
Mar 20241002
Apr 2024602
Total3430122